By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix reported today that its third-quarter revenues increased 20 percent year over year as it trimmed its net loss.

The Irvine, Calif.-based molecular diagnostics service provider reported total revenues of $1.2 million for the three-month period ended Sept. 30, compared to revenues of $1 million for the third quarter of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.